Abeona Therapeutics Inc. (ABEO) DCF Valuation

Abeona Therapeutics Inc. (ABEO) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Abeona Therapeutics Inc. (ABEO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the Abeona Therapeutics Inc. (ABEO) DCF Calculator! Utilize actual financial data from Abeona, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Abeona Therapeutics Inc. (ABEO).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 10.0 3.0 1.4 3.5 3.3 3.1 2.9 2.8 2.6
Revenue Growth, % 0 0 -70 -52.87 147.52 -5.72 -5.72 -5.72 -5.72 -5.72
EBITDA -67.6 -74.5 -76.8 -34.4 -50.6 -2.0 -1.9 -1.8 -1.7 -1.6
EBITDA, % 100 -745.18 -2560.07 -2431.61 -1444.91 -60 -60 -60 -60 -60
Depreciation 8.7 5.6 4.5 4.6 3.2 3.0 2.8 2.6 2.5 2.3
Depreciation, % 100 56.01 148.8 323.69 91.37 89.48 89.48 89.48 89.48 89.48
EBIT -76.3 -80.1 -81.3 -39.0 -53.8 -2.0 -1.9 -1.8 -1.7 -1.6
EBIT, % 100 -801.19 -2708.87 -2755.3 -1536.29 -60 -60 -60 -60 -60
Total Cash 129.3 95.0 45.0 52.1 52.2 3.3 3.1 2.9 2.8 2.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 3.0 .2 2.4
Account Receivables, % 100 0 100 13.3 69.83
Inventories .0 .0 .0 .0 .0 .7 .6 .6 .6 .5
Inventories, % 100 0 0 0 0 20 20 20 20 20
Accounts Payable 3.8 4.7 4.3 1.8 1.9 2.6 2.5 2.3 2.2 2.1
Accounts Payable, % 100 46.95 144.17 128.08 53.09 80.01 80.01 80.01 80.01 80.01
Capital Expenditure -6.5 -1.3 -4.2 -.1 -.3 -.9 -.8 -.8 -.7 -.7
Capital Expenditure, % 100 -13.36 -138.37 -9.19 -9.46 -26.4 -26.4 -26.4 -26.4 -26.4
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -76.7 -84.0 -84.8 -31.2 -53.8 -1.9 -1.8 -1.7 -1.6 -1.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -70.8 -78.8 -87.8 -26.5 -53.1 .9 .2 .2 .1 .1
WACC, % 11.39 11.39 11.39 11.32 11.39 11.38 11.38 11.38 11.38 11.38
PV UFCF
SUM PV UFCF 1.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 1
Present Terminal Value 1
Enterprise Value 2
Net Debt -9
Equity Value 11
Diluted Shares Outstanding, MM 21
Equity Value Per Share 0.52

What You Will Receive

  • Authentic Abeona Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
  • Immediate Valuation Updates: Automatic recalculations to assess the effects of changes on Abeona's fair value.
  • Flexible Excel Template: Designed for quick edits, scenario analysis, and comprehensive projections.
  • Efficient and Precise: Avoid the hassle of building models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical performance and future forecasts for Abeona Therapeutics Inc. (ABEO).
  • Adjustable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins to fit your analysis.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow evaluations.
  • Interactive Dashboard: Utilize user-friendly charts and summaries to easily interpret your valuation findings.
  • Designed for All Users: An intuitive layout suitable for investors, CFOs, and consultants, regardless of experience level.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based ABEO DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
  3. Instant Calculations: The model automatically recalculates Abeona Therapeutics’ intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.

Why Choose This Calculator for Abeona Therapeutics Inc. (ABEO)?

  • Accurate Data: Access to real-time Abeona Therapeutics financials ensures dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you the effort of building from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: An intuitive interface and guided instructions make it accessible for all users.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Abeona Therapeutics Inc. (ABEO) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Abeona Therapeutics Inc. (ABEO).
  • Consultants: Deliver professional valuation insights on Abeona Therapeutics Inc. (ABEO) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Abeona Therapeutics Inc. (ABEO) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Abeona Therapeutics Inc. (ABEO).

What the Template Contains

  • Pre-Filled Data: Includes Abeona Therapeutics Inc.'s (ABEO) historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Abeona Therapeutics Inc.'s (ABEO) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

Es wurden keine passenden Produkte gefunden.